Bayer AG
XETRA:BAYN
Bayer AG
Net Change in Cash
Bayer AG
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Net Change in Cash
€736m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Net Change in Cash
-$145.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Net Change in Cash
€129m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-6%
|
|
MPH Health Care AG
XETRA:93M1
|
Net Change in Cash
-€174.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Net Change in Cash
€7.7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Net Change in Cash
€11.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Net Change in Cash?
Net Change in Cash
736m
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Net Change in Cash amounts to 736m EUR.
What is Bayer AG's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-10%
Over the last year, the Net Change in Cash growth was 21%. The average annual Net Change in Cash growth rates for Bayer AG have been -10% over the past three years .